ArticleBMC surgery2025
Cholecystectomies in the shadow of COVID-19 pandemic: a retrospective analysis of 1075 patients - shift in patient behavior, hospital logistics, and perspectives for the future.
Article in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOur study aimed to depict the influence of the COVID-19 pandemic on patients diagnosed with acute or chronic cholecystitis undergoing cholecystectomy.
methodsA retrospective cohort analysis was performed. The “Pre-pandemic cohort” (January 1, 2018, to March 21, 2020) was compared with the “Pandemic cohort” (March 22, 2020, to December 31, 2021), with March 22 marking the first national lockdown in Germany. A total of 1,075 patients were included (512 pre-pandemic, 563 during the pandemic). Demographic, clinical, perioperative, and postoperative variables were assessed. Descriptive and inferential statistical tests, including the Shapiro-Wilk and Mann-Whitney U tests, were applied.
resultsDemographic profiles remained comparable between groups. Time from symptom onset to hospital presentation rose markedly (1.83 ± 4.75 vs. 8.49 ± 30.63 days, p < 0.001), while hospital workflow efficiency remained unaffected. Emergency procedures (25.4% vs. 31.1%, p = 0.02) and cases of acute cholecystitis (29.1% vs. 42.1%, p = 0.048) increased during the pandemic. Laparoscopic cholecystectomy remained the standard approach, though its relative frequency declined somewhat during the pandemic (89.9% vs. 81.9%), while open procedures tripled (4.2% vs. 13.5%, p < 0.01). Postoperative complication rates rose modestly (11.9% vs. 16.0%, p = 0.055), but did not reach statistical significance.
conclusionThe COVID-19 pandemic significantly altered patient behavior and clinical presentation, leading to more advanced disease and changes in surgical strategy. Despite increased case complexity, hospital logistics and critical outcomes remained robust, underscoring the adaptability of surgical teams to overcome the challenges posed by systemic healthcare crises. Remarkably, our study demonstrates that even in the shadow of a global pandemic, surgical practice does not stand still—strategies shift, workflows adapt, and outcomes endure, offering reassurance that future disruptions can be approached with confidence rather than concern.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.